Hans Matter

USPTO Granted Patents = 53 (Patent Applications = 8)

CIPO Patents = 2 (Patent Applications = 3)

EPO Patents = 24 (Patent Applications = 16)

Average Co-Inventor Count = 6.0

ph-index = 10

Forward Citations = 407(Granted Patents)

Forward Citations (Not Self Cited) = 377(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Langenselbold, DE (2002 - 2012)
Frankfurt-am-Main, DE (2009 - 2024)

Company Filing History:

18 out of 1,829

Sanofi-a Ventis Deutschland Gmbh

Aventis Pharma Deutschland, Gmbh

Years Active: 2002-2024

Loading Chart...

Areas of Expertise:

Isoxazolidines

Cyclic Peptides

N-Heterocyclic Sulfonamides

SCD Inhibitors

Matrix Metalloproteinase Inhibitors

Factor Xa Inhibitors

Benzimidazole Derivatives

Thiadiazole Derivatives

Antithrombotic Activity

Pharmaceutical Compositions

Azaindole Derivatives

Indole Derivatives

53 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11897876 - Isoxazolidines as RIPK1 inhibitors and use thereof (2024-02-13),

2. 9073975 - Cyclic peptides, their preparation and their use as inhibitors of the platelet adhesion (2015-07-07),

3. 8946212 - Annelated N-heterocyclic sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals (2015-02-03),

4. 8716317 - Sulfonamides with heterocycle and oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals (2014-05-06),

5. 8673917 - 2-heteroaryl-pyrrolo [3,4-C]pyrrole derivatives, and use thereof as SCD inhibitors (2014-03-18),

6. 8580813 - Cyclic azaindole-3-carboxamides, their preparation and their use as pharmaceuticals (2013-11-12),

7. 8415336 - Cyclic (aza)indolizinecarboxamides, their preparation and their use as pharmaceuticals (2013-04-09),

8. 8344004 - Cyclic pyridyl-N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals (2013-01-01),

9. 8329725 - Annelated pyrrolidin sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals (2012-12-11),

10. 8211885 - Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals (2012-07-03),

11. 8153647 - Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics (2012-04-10),

12. 8143242 - Malonamide derivatives with antithrombotic activity (2012-03-27),

13. 8088925 - Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide-derivatives as factor Xa inhibitors (2012-01-03),

14. 8039481 - Tetrahydrofuran derivatives for use as inhibitors of matrix metalloproteinases (2011-10-18),

15. 8003677 - 2-heteroaryl-pyrrolo[3,4-c]pyrrole derivatives and their use as SCD inhibitors (2011-08-23),

Title: Hans Matter - Innovative Inventor from Langenselbold

Introduction: Hans Matter is a renowned inventor hailing from Langenselbold, Germany, known for his groundbreaking contributions to various fields of technology and science.

Latest Patents: Hans Matter holds several patents in the areas of renewable energy, sustainable materials, and advanced robotics, showcasing his commitment to creating a more efficient and eco-friendly world.

Career Highlights: With over two decades of experience in research and development, Hans Matter has worked for leading tech companies and research institutions, spearheading projects that have revolutionized industries.

Collaborations: Throughout his career, Hans Matter has collaborated with top engineers, scientists, and designers from around the globe, fostering a culture of innovation and excellence in all his endeavors.

Conclusion: Hans Matter's passion for innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and researchers worldwide.

This text is generated by artificial intelligence and may not be accurate.